(NASDAQ: LEGN) Legend Biotech's forecast annual revenue growth rate of 85.32% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.5%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.08%.
Legend Biotech's revenue in 2024 is $285,143,000.On average, 6 Wall Street analysts forecast LEGN's revenue for 2024 to be $209,007,774,555, with the lowest LEGN revenue forecast at $163,719,931,050, and the highest LEGN revenue forecast at $237,721,339,885. On average, 6 Wall Street analysts forecast LEGN's revenue for 2025 to be $425,194,486,175, with the lowest LEGN revenue forecast at $318,344,310,375, and the highest LEGN revenue forecast at $555,156,095,087.
In 2026, LEGN is forecast to generate $665,975,933,482 in revenue, with the lowest revenue forecast at $569,490,684,606 and the highest revenue forecast at $848,251,153,874.